ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menéndez, R.
Right arrow Articles by Perpiñá, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menéndez, R.
Right arrow Articles by Perpiñá, M.
Eur Respir J 2001; 18:151-156
Copyright ©ERS Journals Ltd 2001


Initial risk class and length of hospital stay in community-acquired pneumonia

R. Menéndez, D. Ferrando, J.M. Vallés, E. Martínez and M. Perpiñá

Service of Pneumology, Hospital Universitario La Fe, Valencia, Spain

CORRESPONDENCE: R. Menéndez, Servicio de Neumología, Hospital Universitario La Fe, Avda. de Campanar 21, E-46009, Valencia, Spain. Fax: 34 963987397

Keywords: community-acquired pneumonia, length of stay, risk class

Received: October 17, 2000
Accepted March 15, 2001

The total medical costs of community-acquired pneumonia are directly related to the costs of hospital admission and length of stay. The aim of the present study was to evaluate the reasons for prolonged duration of stay in patients stratified in five risk classes for death, and to identify factors associated with prolonged stay.

The study population consisted of 295 patients. According to lower (classes I, II, III) or to higher (classes IV, V) risk, the target duration of hospitalization was set at 5 and 7 days, respectively. The causes of prolonged hospitalization were classified as pneumonia-related, complications, unstable comorbid diseases and nonclinical factors.

The overall percentage of patients with appropriate duration of hospitalization was 32%. Causes of prolonged hospitalization were related mainly to pneumonia (32%) from all risk classes. Morbid complications and instability of the underlying illness were greater in class V patients. Nonclinical factors were present in 29.5% of cases. Hypoxaemia, anaemia, hypoalbuminaemia, and complications appearing before 72 h were associated with prolonged hospitalization.

The cause of prolonged hospitalization of patients with community-acquired pneumonia is multifactorial, depending mainly on pneumonia and comorbid conditions but there is a large number of unnecessary hospitalization days that could be reduced by improving the efficiency of hospital care.




This article has been cited by other articles:


Home page
BiostatisticsHome page
J. Beyersmann and M. Schumacher
Time-dependent covariates in the proportional subdistribution hazards model for competing risks
Biostat., April 22, 2008; (2008) kxn009v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. W. Arnold, J. T. Summersgill, A. S. LaJoie, P. Peyrani, T. J. Marrie, P. Rossi, F. Blasi, P. Fernandez, T. M. File Jr., J. Rello, et al.
A Worldwide Perspective of Atypical Pathogens in Community-acquired Pneumonia
Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 1086 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. M. Verheij
Guidelines for the management of adult lower respiratory tract infections
Eur. Respir. J., December 1, 2005; 26(6): 1138 - 1180.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M M van der Eerden, F Vlaspolder, C S de Graaff, T Groot, W Bronsveld, H M Jansen, and W G Boersma
Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study
Thorax, August 1, 2005; 60(8): 672 - 678.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R Menendez, A Torres, R Zalacain, J Aspa, J J Martin Villasclaras, L Borderias, J M Benitez Moya, J Ruiz-Manzano, F Rodriguez de Castro, J Blanquer, et al.
Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome
Thorax, November 1, 2004; 59(11): 960 - 965.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. Menendez, M.J. Cremades, E. Martinez-Moragon, J.J. Soler, S. Reyes, and M. Perpina
Duration of length of stay in pneumonia: influence of clinical factors and hospital type
Eur. Respir. J., October 1, 2003; 22(4): 643 - 648.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P.P. Espana, A. Capelastegui, J.M. Quintana, A. Soto, I. Gorordo, M. Garcia-Urbaneja, and A. Bilbao
A prediction rule to identify allocation of inpatient care in community-acquired pneumonia
Eur. Respir. J., April 1, 2003; 21(4): 695 - 701.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Menendez, D. Ferrando, J. M. Valles, and J. Vallterra
Influence of Deviation From Guidelines on the Outcome of Community-Acquired Pneumonia*
Chest, August 1, 2002; 122(2): 612 - 617.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.